Gujarat Themis Biosyn Publishes Newspaper Advertisement for Postal Ballot
Gujarat Themis Biosyn Limited published a newspaper advertisement on July 24, 2026, regarding a postal ballot. Members can cast their votes remotely from July 24, 2026, to August 22, 2026, on resolutions concerning fundraising via QIP, AoA amendment, and NCD/debt security placement. Results will be announced by August 25, 2026.
This is a standard procedural announcement for seeking shareholder approval on corporate actions and does not have an immediate material impact on the company's operations or financial performance.
The announcement is a routine regulatory filing regarding a postal ballot and does not contain any information that would positively or negatively impact the company's stock price.
Gujarat Themis Biosyn Limited has published a newspaper advertisement in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice of the Postal Ballot was published in the 'Western Times' (English) and 'Western Times' (Gujarati) editions on Friday, July 24, 2026.
This advertisement is in pursuance of Regulation 30 read with Schedule III (A) (12) of the SEBI Listing Regulations. The company has engaged Central Depository Services (India) Limited (CDSL) to provide e-voting facility for the postal ballot. The remote e-voting period commenced on Friday, July 24, 2026, at 9:00 a.m. (IST) and will conclude on Saturday, August 22, 2026, at 05:00 p.m. (IST). The company is seeking approval from its members via postal ballot through remote electronic voting for three special resolutions: raising funds by issue of Equity Shares through Qualified Institutions Placement, amendment to the Articles of Association, and private placement of NCDs and/or Debt securities.
The Board of Directors has appointed Mr. Ketan R. Shirwadkar as the Scrutinizer for the e-voting process. The results of the Postal Ballot will be announced within 2 working days of receiving the Scrutinizer's Report, i.e., by Tuesday, August 25, 2026, and will be placed on the company's website and forwarded to the stock exchanges.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.